RoboSense Adds GWM WEY to Its List of Design Wins on Top of 50+ Models
14.9.2022 17:02:00 EEST | Business Wire | Press release
RoboSense, a world-leading provider of Smart LiDAR Sensor Systems today announced that it will provide LiDAR for Great Wall Motor WEY Mocha DHT-PHEV LiDAR Edition. On the same day, WEY Mocha DHT-PHEV LiDAR Edition was officially launched at the 25th Chengdu International Auto Show.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220826005302/en/
Great Wall Motor WEY Mocha SUV equipped with two RS-LiDAR-M1
Based on WEY’s Mocha DHT-PHEV LiDAR Edition, RoboSense, together with Haomo.AI and Qualcomm, jointly created the urban driving assistance solution NOH for WEY. In particular, RoboSense second-generation smart solid-state LiDAR (RS-LiDAR-M1) are deployed under the headlights on both sides of the vehicle, one on each side, which give Mocha DHT-PHEV accurate perception capabilities and provide an extra level of perception safety redundancy. Adopting the perception-focused technology path, Mocha DHT-PHEV can perceive, think and make decisions like a human being, and full coverage of China’s high-speed and urban road commuting scenes is realized - smarter intelligence for driving assistance; safer and cozier driving experience for consumers.
With the large-scale application of intelligent driving technologies, the increasingly more complex application scenarios put higher automotive-grade reliability requirements for LiDAR on the front side of the vehicle body. Mocha DHT-PHEV’s intelligent driving application scenarios cover all kinds of high-speed and urban road conditions. Complex road conditions will bring various challenges to LiDAR.
RS-LiDAR-M1 adopts highly-integrated design, and has passed a series of reliability tests in accordance with strict passenger vehicle standards, including mechanical shock, random vibration, high-pressure water impact, high and low temperature operation, high and low temperature damp heat, solar radiation, EMC, chemical anti-corrosion, salt spray and other tests. It fully meets the safety, reliability and service life requirements of Mocha DHT-PHEV in complex high-speed and urban road scenarios.
Meanwhile, thanks to the revolutionary 2D MEMS LiDAR technology platform, M1’s unique smart “GAZE” function can dynamically switch scanning modes according to different scenarios such as high-speed railways and urban areas, giving urban NOH ADAS solution the differentiated scenario perception capability, safeguarding and ensuring the smart driving experience of Mocha DHT-PHEV LiDAR Edition.
With its leading technological strengths in the field of LiDAR, RoboSense has obtained design wins for more than 50 models from companies including Great Wall Motor, BYD, FAW Hongqi, GAC AION, ZEEKR, WM Motor, Lotus Cars, Lucid Motors, Inceptio Technology and Zhito Technology. RoboSense will always pursue technological innovation and keep promoting the large-scale production of smart vehicles.
About RoboSense
RoboSense is a world-leading provider of Smart LiDAR Sensor Systems. With a complete portfolio of LiDAR sensors, AI perception and IC chipsets, RoboSense transforms conventional 3D LiDAR sensors with comprehensive data analysis and interpretation systems. Its mission is to innovate outstanding hardware and AI capabilities to create smart solutions that enable robots, including autonomous vehicles, to have perception capabilities superior to humans.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220826005302/en/
Contact information
Grace Ye
media@robosense.ai
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom